Two-Drug HIV Therapy Effective Without Resistance Testing

Dolutegravir plus lamivudine shows comparable efficacy and safety with standard-of-care three-drug regimen in patients with HIV without preliminary drug resistance testing in a phase 4 trial.
Medscape Medical News

source https://www.medscape.com/viewarticle/two-drug-hiv-regimen-matches-standard-care-therapy-absence-2025a10006aw?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?